Last reviewed · How we verify
NCT06789016
Dexmedetomidine for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery
Phase 4 trial testing Dexmedetomidine in Scoliosis Idiopathic in 60 participants. Completed in 31 March 2026.
25 March 2026
Quick facts
| Lead sponsor | Poznan University of Medical Sciences |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 February 2025 |
| Primary completion | 25 March 2026 |
| Estimated completion | 31 March 2026 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- Dexmedetomidine (dexmedetomidine) — full drug profile →
- 0.9%NaCl
Conditions studied
- Scoliosis Idiopathic — all drugs for Scoliosis Idiopathic →
- Scoliosis — all drugs for Scoliosis →
- Scoliosis; Adolescence — all drugs for Scoliosis; Adolescence →
Sponsor
Poznan University of Medical Sciences
Who can join
Adults 10 to 18, any sex, with Scoliosis Idiopathic or Scoliosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Effect of perineurial dexmedetomidine on erector spinal plane block duration for pediatric, idiopathic scoliosis surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06789016
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dexmedetomidine
Trials testing the same drug.
- NCT06824077 — Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle · EARLY_PHASE1 · not yet recruiting
- NCT07398066 — DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial) · NA · not yet recruiting
- NCT07377981 — An Exploratory Study of the Efficacy and Safety of Esketamine and Dexmedetomidine in Non-Intubated ICU Patients With Hyp · Phase 4 · not yet recruiting
- NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
- NCT07306702 — Dexmedetomidine-Enhanced PCIA After Lobectomy in Nicotine-Dependent Patients · Phase 4 · withdrawn
Other recruiting trials for Scoliosis Idiopathic
Currently open trials in the same condition.
- NCT07403084 — Post-market Clinical Follow-up Study of NEMOST V2 · NA · recruiting
- NCT07059663 — Synergic Effects of Schroth Method With and Without Core Stabilization Exercises in Idiopathic Scoliosis Patients · NA · recruiting
- NCT06242821 — Yoga for Back Pain in Adolescent Scoliosis · NA · recruiting
- NCT06884150 — fNIRS-based Analysis and Evaluation of the Effect of Schroth Rehabilitation on Motor Functions in Adolescent Idiopathic · NA · active not recruiting
- NCT06992622 — Zhejiang Adolescent Spine and Vision Health Cohort: A Longitudinal Database Analysis · recruiting
Other Poznan University of Medical Sciences trials
Trials by the same sponsor.
- NCT07449468 — PENG Block and Delirium After Hip Arthroplasty · NA · not yet recruiting
- NCT07449442 — SII Levels Following iPACK Block With Adductor Canal Block in Knee Arthroplasty · NA · not yet recruiting
- NCT07474909 — Perineural vs Intravenous Dexamethasone as an Adjuvant to Brachial Plexus Block in Pediatric Hand Surgery · NA · not yet recruiting
- NCT07474896 — Diaphragm-Sparing Regional Anesthesia Techniques for Shoulder Surgery · NA · not yet recruiting
- NCT07449403 — SII Levels Following PENG Block in Hip Arthroplasty · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06789016 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Poznan University of Medical Sciences
- Last refreshed: 13 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06789016.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing